Finally, the strengths of this research lie in the fact that it was determined that the IL-6 and NLR values, which are immediately available, low-cost, affordable laboratory markers in basic instrumentation laboratories, represent prognostic alternatives for critically ill patients with severe COVID-19 at high altitude in low-resource settings. The gene discussed is IL6; the disease is COVID-19.